Diffusion-Weighted Magnetic Resonance Imaging Allows Noninvasive In Vivo Monitoring of the Effects of Combretastatin A-4 Phosphate after Repeated Administration

Article English OPEN
Harriet C. Thoeny ; Frederik De Keyzer ; Feng Chen ; Vincent Vandecaveye ; Erik K. Verbeken ; Bisan Ahmed ; Xihe Sun ; Yicheng Ni ; Hilde Bosmans ; Robert Hermans ; Allan van Oosterom ; Guy Marchal ; Willy Landuyt (2005)
  • Publisher: Elsevier
  • Journal: Neoplasia: An International Journal for Oncology Research, volume 7, issue 8, pages 779-787 (issn: 1476-5586, eissn: 1522-8002)
  • Related identifiers: doi: 10.1593/neo.04748
  • Subject: necrosis | CA4-P | RC254-282 | anticancer therapy | vascular targeting | DW-MRI | Neoplasms. Tumors. Oncology. Including cancer and carcinogens

The noninvasive assessment of anticancer treatment efficacy is very important for the improvement of therapeutic window. The purpose of the present study was to evaluate the antitumoral effects of the vascular targeting agent, combretastatin A-4 phosphate (CA-4-P), at s... View more
Share - Bookmark